CG:600513 Jiangsu Lianhuan Pharmaceutical Co., Ltd

Jiangsu Lianhuan Pharmaceutical Co., Ltd. is principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company's main products are anti-allergic agents, cardio-vascular drugs and urological surgery drugs, including felodipine tablets, ebastine tablets, terfenadine tablets, lumbrokinase enteric-coated capsules, simvastatin tablets, danazol capsules, cetirizine hydrochloride tablets, troxerutin tablets, lithium carbonate tablets, guaifenesin pseudoephedrine hydrochloride and dextromethorphan hydrobromide capsules, doxycycline hyclate tablets and sodium prasterone sulfate for injection, among others. The Company distributes its products principally in domestic markets.

8.35 CNY
As of 01/27/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Unknown
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  03/20/2003
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   2,468,074,240 CNY
Current dividend yield:   1.21%
Sedol:      

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy